<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(1)</volume><submitter>Cisternas P</submitter><pubmed_abstract>&lt;b>Background/Objectives:&lt;/b> Astrocytes are key regulators of brain energy homeostasis, integrating glucose metabolism with antioxidant support for neuronal function. Dysregulation of these processes contributes to neurodegenerative diseases, including Alzheimer's disease. Andrographolide, a bioactive diterpenoid from &lt;i>Andrographis paniculata&lt;/i>, has been reported to exert neuroprotective effects through the modulation of Wnt/β-catenin signaling and neuronal metabolism; however, its actions on astrocytic metabolic pathways remain insufficiently characterized. &lt;b>Methods:&lt;/b> Here, we investigated the effects of andrographolide on metabolic and redox parameters in primary mouse cortical astrocytes. &lt;b>Results:&lt;/b> Andrographolide increased glucose uptake and antioxidant capacity without affecting AMPK activation or the activity of core glycolytic enzymes. Instead, it selectively enhanced glucose-6-phosphate dehydrogenase activity, promoting glucose flux through the pentose phosphate pathway in a partially Wnt-dependent manner. This metabolic reprogramming was associated with increased NADPH availability and glutathione levels, together with a reduced ATP/ADP ratio, consistent with a shift toward redox maintenance rather than maximal energy production. &lt;b>Conclusions:&lt;/b> Collectively, these findings highlight astrocytic metabolic plasticity as a relevant and underexplored target of andrographolide and support the concept that natural compounds can enhance brain resilience by modulating glial redox metabolism.</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pagination>133</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12845274</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes.</pubmed_title><pmcid>PMC12845274</pmcid><pubmed_authors>Ormazabal P</pubmed_authors><pubmed_authors>Cisternas P</pubmed_authors><pubmed_authors>Bastias-Perez M</pubmed_authors><pubmed_authors>Inestrosa NC</pubmed_authors><pubmed_authors>Gherardelli C</pubmed_authors><pubmed_authors>Brito-Valenzuela J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes.</name><description>&lt;b>Background/Objectives:&lt;/b> Astrocytes are key regulators of brain energy homeostasis, integrating glucose metabolism with antioxidant support for neuronal function. Dysregulation of these processes contributes to neurodegenerative diseases, including Alzheimer's disease. Andrographolide, a bioactive diterpenoid from &lt;i>Andrographis paniculata&lt;/i>, has been reported to exert neuroprotective effects through the modulation of Wnt/β-catenin signaling and neuronal metabolism; however, its actions on astrocytic metabolic pathways remain insufficiently characterized. &lt;b>Methods:&lt;/b> Here, we investigated the effects of andrographolide on metabolic and redox parameters in primary mouse cortical astrocytes. &lt;b>Results:&lt;/b> Andrographolide increased glucose uptake and antioxidant capacity without affecting AMPK activation or the activity of core glycolytic enzymes. Instead, it selectively enhanced glucose-6-phosphate dehydrogenase activity, promoting glucose flux through the pentose phosphate pathway in a partially Wnt-dependent manner. This metabolic reprogramming was associated with increased NADPH availability and glutathione levels, together with a reduced ATP/ADP ratio, consistent with a shift toward redox maintenance rather than maximal energy production. &lt;b>Conclusions:&lt;/b> Collectively, these findings highlight astrocytic metabolic plasticity as a relevant and underexplored target of andrographolide and support the concept that natural compounds can enhance brain resilience by modulating glial redox metabolism.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-11T03:13:52.176Z</modification><creation>2026-06-11T03:08:39.041Z</creation></dates><accession>S-EPMC12845274</accession><cross_references><pubmed>41599730</pubmed><doi>10.3390/ph19010133</doi></cross_references></HashMap>